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The incidence of cardiac implantable electronic device (CIED) infections is rapidly
increasing worldwide. However, the microbiological characteristics and clinical features
of symptomatic CIED infections are not well described. The present study included
patients with CIED infections in China, and their pocket tissues were collected for
clinical microbiological determination. A total of 219 patients with CIED infections were
investigated; of these patients, 145 (66.2%) were positive for CIED infection in pocket
tissue cultures and 24 (11.0%) were positive in both blood and pocket tissue cultures.
Patients with recurrent infections and patients with systemic infections tended to have
higher rates of positive cultures from pocket tissue. In addition, patients with lung
diseases were more likely to have early CIED infections than late CIED infections, while
patients with liver diseases were more susceptible to systemic infections than local
infections. Staphylococcus species were the most common cause of CIED infections;
coagulase-negative staphylococci was the predominant type (accounting for 45.2% in
all cases and 68.3% in culture-positive cases). None of the Staphylococcus isolates
were resistant to gentamicin, linezolid or vancomycin. Gram-negative bacilli accounted
for 9.1% of all cases and 13.8% of culture-positive cases. Significant differences in
the distribution of different pathogens were identified between primary infections and
recurrent infections, between local infections and systemic infections, and between early
infections and late infections. Our data describe the microbiological characteristics and
clinical features of CIED infections, and provide evidence for advisory guidelines on the
management of CIED infections in China.
Keywords: Cardiac implantable electronic device (CIED) infection, pocket, culture, microbial diagnosis, clinical
characteristics
INTRODUCTION
Cardiac implantable electronic device (CIED) infection, is a major complication following
implantation of these devices and represents a broad range of symptoms, varying from local
complaints at the pulse generator pocket and/or the subcutaneous portion of the leads, to severe
systemic manifestations (Tarakji et al., 2010; Sohail et al., 2011; De Bie et al., 2012). Accumulating
evidence has suggested an increased rate of CIED infections worldwide due to continuous growth
in the utilization of CIEDs (Cabell et al., 2004; Zhan et al., 2008; Mond and Proclemer, 2011).
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Data from the United States have indicated a 3.1-fold increase
in the number of hospitalizations for CIED infection between
1996 and 2003 (Voigt et al., 2006). Patients with CIED infection
often have prolonged hospital stay, increased financial burden
and higher rates of in-hospital morbidity and mortality. It has
been shown that CIED infection increases the risk of in-hospital
death by more than twofold (Voigt et al., 2006). In addition,
increased mortality persists even after hospital discharge (De Bie
et al., 2012), highlighting the need to maximize infection control
measures in settings in which CIED infection is likely to occur.
Staphylococcus species, including coagulase-negative
staphylococci (CoNS), methicillin-sensitive Staphylococcus
aureus (MSSA), and methicillin-resistant Staphylococcus aureus
(MRSA), are by far the most common microbiologic causes of
CIED infections, accounting for 60%–80% of all CIED infections
(Greenspon et al., 2012; Habib et al., 2013; Rickard et al.,
2013; Aydin et al., 2016). However, unusual organisms, such
as Gram-negative bacilli, are also present in CIED infections.
The majority of CIED infections are pocket infections; however,
when the infection moves to the intravascular portion of the
leads, intravascular infection can occur, resulting in bacteremia
and endocarditis. Interestingly, it was shown that the incidence
of CIED infection in the setting of S. aureus bacteremia could
reach 55% (Uslan et al., 2007). In addition, Gram-negative and
non-staphylococcal bacteremia can also cause CIED infection,
although these infections are usually associated with lower
morbidity and mortality (Viola et al., 2010). Therefore, an
understanding of the microbiologic risk factors/microbial
epidemiology of CIED infections is critical for the selection of
both antimicrobial prophylaxis and initial empirical treatments,
as the microbiology of CIED infections is closely associated with
the pathogenesis of infection.
Two studies have recently described the asymptomatic
bacterial colonization of CIEDs in China (Chu et al., 2014;
Zou et al., 2014). However, there are limited data regarding
the microbiological characteristics and clinical features of
symptomatic CIED infections in China. It is of paramount
importance to draw a basic picture of the characteristics of
symptomatic CIED infections, as this information will provide
valuable insights into the pathogenesis, implementation of
preventive measures and treatment of CIED infections, especially
when considering the rapid increase in methicillin-resistant
Staphylococcus species in China (Zhao et al., 2012).
MATERIALS AND METHODS
Patients and Case Definitions
From November 2011 to November 2014, a total of 219
consecutive patients with sufficient evidence of CIED infection
were included. Patients with CIED infections were defined as
the presence of early post-implantation infections; generator
pocket infections; constitutional symptoms or CIED-related lead
infection or infectious endocarditis (CIED-LI/IE), as previously
described (Chinese Heart Rhythm Society, 2013; Sandoe et al.,
2015a). Specifically, an early post-implantation infection case
was defined as erythema affecting the implantation incision
site, without purulent exudate, exposed devices, or systemic
signs of infection. Generator pocket infection was defined as
the device penetrating through the skin or purulent exudate
without systemic signs. Constitutional symptoms included
positive blood cultures, and fever or chills without vegetation
on the leads or cardiac valves. If vegetation was found
by transesophageal echocardiography (TEE), a diagnosis of
CIED-LI/IE was considered. Oral anticoagulant treatment was
stopped before CIED-related procedures. The demographics and
clinical characteristics of all patients with CIED infections are
shown in Table 1. Overall, patients with hypertension exhibited
the highest prevalence of CIED infections (48.4%), followed
by patients with diabetes mellitus (24.2%). The incidence of
early post-implantation infections, generator pocket infections,
constitutional symptoms, and CIED-LI/IE was 14.6% (32/219),
69.4% (152/219), 11.0% (24/219), and 5.0% (11/219), respectively.
Positive cultures were identified in 145 patients with CIED
infection (24 patients were positive for both blood culture and
pocket tissue culture; 121 patients were positive for pocket
tissue culture), accounting for 66.2% of all patients. The median
length of stay was 15 days, and the in-hospital mortality was
0.9% (2/219). Study protocols were reviewed and approved by
the Ethical Committee of Peking University People’s Hospital.
TABLE 1 | Clinical information and demographics of patients with cardiac
implantable electronic device (CIED) infection.
N = 219
Demographics
Median age at study (max, min), years 68 (58− 77)
Male, n (%) 161 (73.5)
Median duration of infection (max, min), days 23 (10− 37)
Underlying diseases
Lung diseases, n (%) 23 (10.5)
Renal diseases, n (%) 27 (12.3)
Liver diseases, n (%) 24 (11.0)
Diabetes mellitus, n (%) 53 (24.2)
Hypertension, n (%) 106 (48.4)
Types of infection
Early post-implantation inflammation, n (%) 32 (14.6)
Generator pocket infection, n (%) 152 (69.4)
Constitutional symptoms, n (%) 24 (11.0)
CIED-LI/IE∗, n (%) 11 (5.0)
Positive culture results
Blood, n (%) 24 (11.0)
Pocket tissue, n (%) 145 (66.2)
Treatment
Re-implantation, n (%) 137 (62.6)
Inappropriate empirical antimicrobial therapy 68 (31.1)
Definitive antimicrobial therapy∗∗, n (%) 79 (36.1)
Outcome
Median length of stay (max, min), days 15 (13− 20)
In-hospital death, n (%) 2 (0.9)
∗CIED-LI/IE, cardiac implantable electronic device associated lead infection or
infectious endocarditis; CoNS, coagulase-negative staphylococci. ∗∗Definitive
antimicrobial therapy refers to the corrected therapy when microbiology results and
antimicrobial susceptibility data were available.
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Informed consent was not needed as this study was retrospective
and participants were anonymized.
Specimen Collection and Culture
Pocket tissue was collected during device extraction. Each
specimen (approximately 1 cm3 in size) was obtained using an
aseptic technique. Pocket tissue samples for culture were placed
in sterile bottles and transported to the clinical microbiology
laboratory within 12 h. Samples were inoculated onto solid
media (blood agar, eosin methylene blue agar, chocolate agar,
and Sabouraud agar, Oxoid, Basingstoke, Hampshire, UK).
Identification and antimicrobial susceptibility testing were
performed using the Vitek 2 automated system (bioMérieux,
Marcy-l’Etoile, France). Minimum inhibitory concentrations
(MICs) were determined according to Clinical and Laboratory
Standards Institute (CLSI) breakpoints (Cockerill, 2011; Patel,
2014).
Statistical Analysis
The chi-squared or Fisher’s exact test were used for categorical
variables. Ordinal and continuous variables were presented
as median (interquartile range) and determined by the
Mann–Whitney U test. A p-value less than 0.05 was considered
statistically significant. SPSS 19 (SPSS Inc., Chicago, IL, USA)
statistical software was used for data analysis.
RESULTS
Comparison of Clinical Characteristics
of CIED Infections between Patients with
Primary Infections and Patients with
Recurrent Infections
Of all CIED infections, 112 cases were primary infections and
107 cases were recurrent infections (Table 2). Importantly,
the incidence of positive cultures from pocket tissue was
significantly higher in patients with recurrent infections than in
patients with primary infections (p = 0.020). A trend of higher
incidence of positive cultures from blood was also observed in
patients with recurrent infections than in patients with primary
infections (p = 0.064). Cases for definitive antimicrobial therapy
included 45.3% of patients with recurrent infections, which was
significantly higher than that in patients with primary infections
(p = 0.010). Interestingly, the only two cases of in-hospital
mortality were observed in patients with recurrent infections.
However, no significant difference was observed in the median
length of stay between patients with primary infections and
patients with recurrent infections (Table 2).
Comparison of Clinical Characteristics
between Patients with Early CIED
Infections and Patients with Late CIED
Infections
Early CIED infection was defined as CIED infection occurring
within 6 months of CIED-related procedures (Sandoe et al.,
2015a). Overall, 49 patients (22.4%) were identified as having
early CIED infection and 170 patients (77.6%) were identified as
having late CIED infection (Table 3). In particular, patients with
lung diseases were more likely to have early CIED infections (OR,
2.857; p = 0.016). In addition, patients with diabetes mellitus
exhibited a trend of higher incidence of early infections compared
to late infections (p = 0.052). No significant difference was
observed in the median length of stay between patients with early
CIED infections and patients with late CIED infections (Table 3).
Comparison of Clinical Characteristics
between Patients with Local CIED
Infections and Patients with Systemic
CIED Infections
The differences in clinical characteristics between patients with
local CIED infections and patients with systemic CIED infections
were investigated (Table 4). The results showed that patients with
liver diseases were more susceptible to systemic infections than
local infections (OR, 3.338; p= 0.012). In addition, a significantly
higher rate of positive cultures from pocket tissue was observed
TABLE 2 | Comparison of clinical characteristics and outcomes between primary and recurrent CIED infections.
Characteristics Primary infection (N = 112) Recurrence (N = 107) p
Infection features
Median duration of infection occurrence after last procedure (max, min), months 24 (11.35–47) 16 (6–36) 0.171
Systemic infection, n (%) 15 (13.4) 21 (19.6) 0.213
Positive culture results
Pocket tissue, n (%) 66 (58.9) 79 (73.8) 0.020∗
Blood, n (%) 8 (8.4) 16 (19.0) 0.064
Treatment
Inappropriate empirical antimicrobial therapy, n (%) 35 (32.1) 33 (31.1) 0.877
Definitive antimicrobial therapy, n (%) 31 (28.4) 48 (45.3) 0.010∗
Outcomes
Median length of stay (max, min), days 15 (13–19.75) 15 (12–20) 0.916
In-hospital death, n (%) 0 2 (1.9) 0.146
∗p < 0.05.
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in patients with systemic infections (p = 0.006). These patients
consistently exhibited a higher rate of definitive antimicrobial
therapy (p = 0.01). Moreover, the median length of stay was
significantly longer in patients with systemic infections compared
to patients with local infections (p< 0.001).
Microbiological Characteristics of CIED
Infections
In all 145 cases who had a positive culture, 140 cases
(96.6%) were monomicrobial infections, and the other five cases
were polymicrobial infections (Figure 1). The polymicrobials
identified in these five cases were Pseudomonas aeruginosa and
Klebsiella oxytoca, Staphyloccocus epidermidis and Staphyloccocus
sciuri, S. epidermidis and Bacillus cereus, S. epidermidis and
Sphingomonas paucimobilis, and Enterococcus faecalis and
S. aureus, respectively.
Coagulase-negative staphylococci were the most frequently
isolated pathogens, accounting for 45.2% of all cases, followed
by non-fermentative bacilli (5.9%) and S. aureus (4.1%).
Gram-negative bacilli were identified in 20 cases, accounting for
9.1% of all cases and 13.8% of culture-positive cases.
The distribution of different pathogens was determined
between primary infections and recurrent infections, between
local infections and systemic infections, and between early
infections and late infections. Importantly, recurrent infections
exhibited a higher prevalence of CoNS and non-fermentative
bacilli, and a lower prevalence of negative culture and Candida
compared to primary infections. In addition, non-fermentative
bacilli were more easily detected in systemic infections than
in local infections (16.7% vs. 3.8%). Furthermore, S. aureus
was more likely to cause early infections than late infections
(Figure 1).
In vitro Antimicrobial Susceptibility
Testing
In vitro antimicrobial susceptibility testing was performed on
all culture-positive pathogens. Generally, the prevalence of
methicillin resistance among S. aureus, S. epidermidis, and
TABLE 3 | Comparison of clinical characteristics and outcomes between early and late CIED infections.
Characteristics Early infection (≤6 months)
(N = 49)
Late infection (>6 months)
(N = 170)
p OR (95%CI)
Underlying diseases
Lung diseases, n (%) 10 (20.4) 14 (8.2) 0.016 2.857 (1.180-6.917)
Renal diseases, n (%) 5 (10.2) 18 (10.6) 0.938
Liver diseases, n (%) 4 (8.2) 23 (13.5) 0.314
Diabetes mellitus, n (%) 17 (34.7) 36 (21.2) 0.052
Hypertension, n (%) 25 (51.0) 81 (47.6) 0.677
Positive test results
TEE∗, n (%) 4 (8.2) 7 (4.1) 0.253
Blood culture, n (%) 8 (16.3) 16 (9.4) 0.107
Pocket tissue culture, n (%) 35 (71.4) 110 (64.7) 0.381
Outcomes
Median length of stay (max, min), days 15 (12− 19) 15 (13− 20) 0.694
In-hospital death, n (%) 1 (2.0) 1 (0.6) 0.346
∗TEE, transesophageal echocardiography.
TABLE 4 | Comparison of clinical characteristics, treatment and outcomes between local and systemic CIED infections.
Characteristics Local infection (N = 183) Systemic infection (N = 36) p OR (95% CI)
Underlying diseases
Lung diseases, n (%) 21 (11.5) 3 (8.3) 0.581
Renal diseases, n (%) 24 (13.1) 3 (8.3) 0.425
Liver diseases, n (%) 15 (8.2) 8 (22.2) 0.012∗ 3.338 (1.292–8.626)
Diabetes mellitus, n (%) 44 (24.0) 9 (25.0) 0.903
Hypertension, n (%) 93 (50.8) 13 (36.1) 0.106
Positive pocket tissue culture, n (%) 114 (62.3) 31 (86.1) 0.006∗
Treatment
Inappropriate empirical antimicrobial therapy, n (%) 54 (30.2) 14 (38.9) 0.305
Definitive antimicrobial therapy, n (%) 59 (33.0) 20 (55.6) 0.010∗
Outcomes
Median length of stay (max, min), days 15 (12− 18) 20.5 (14.25− 28) < 0.001∗
In-hospital death, n (%) 2 (1.1) 0 0.529
∗p < 0.05.
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FIGURE 1 | Pathogen distribution in patients with cardiac implantable electronic device (CIED) infections. (A) Pocket tissue culture results of 219 patients
with CEED infections. (B) Pathogen distribution in patients with primary and recurrent CIED infections. (C) Pathogen distribution in patients with local and systemic
CIED infections. (D) Pathogen distribution in patients with early and late CIED infections.
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remaining CoNS was 11.1, 66.2, and 44.0%, respectively. The
resistance rates to erythromycin and clindamycin among these
Staphylococcus species were 44.4%, 51.4% and 44.0%, 22.2%,
21.6%, and 12.0%, respectively. None of these Staphylococcus
species were resistant to gentamicin, linezolid or vancomycin
(Table 5).
Comparison of Clinical Characteristics
between Gram-Positive Infections and
Gram-Negative Infections
The clinical characteristics between Gram-positive infections
and Gram-negative infections were assessed (Table 6). Of note,
in comparison with patients infected by Gram-positive cocci,
patients infected by Gram-negative bacilli showed a significantly
higher incidence of exposed devices (50.0% vs. 23.2%), fever or
chills (25.0% vs. 4.5%), and vegetation (20.0% vs. 5.4%). However,
no significant difference in length of stay was noted between
patients infected by Gram-positive cocci and patients infected by
Gram-negative bacilli. The incidence of antimicrobial adjustment
based on the culture results in patients infected by Gram-negative
bacilli was 45.0%, which was significantly higher than that in
patients infected by Gram-positive cocci (17.0%) (p= 0.005).
DISCUSSION
In this study, we comprehensively analyzed the microbiological
characteristics and clinical features of CIED infections in China.
To our knowledge, this is the first and the largest study regarding
CIED infections in China. The major findings in this study are
as follows: (1), patients with recurrent infections and patients
with systemic infections tended to have higher rates of positive
cultures from pocket tissue; (2), patients with lung diseases
were more likely to have early CIED infections than late CIED
infections; (3), patients with liver diseases were more susceptible
to systemic infections than local infections; (4), Staphylococcus
species were the most common cause of CIED infections with
CoNS the predominant type; Gram-negative bacilli accounted
for 9.1% of all cases and 13.8% of culture-positive cases; (5),
significant differences in the distribution of different pathogens
existed between primary infections and recurrent infections,
between local infections and systemic infections, and between
early infections and late infections; and 6), none of the
Staphylococcus isolates were resistant to gentamicin, linezolid or
vancomycin.
In this study, CoNS, which are part of the normal skin flora,
were responsible for the majority of CIED infections (45.2% in all
cases and 68.3% in culture-positive cases), indicating that most
CIED infections were introduced at the time of implantation, as
suggested by other studies (Bongiorni et al., 2012; Emilie et al.,
2012; Nagpal et al., 2012). Interestingly, infections caused by
S. aureus were only detected in 4.1% of all cases and in 6.2%
of culture-positive cases. In addition, Gram-negative bacterial
infections were identified in 9.1% of all cases and in 13.8% of
culture-positive cases. A retrospective study of 189 cases of CIED
infections at a single center in the United Stated revealed that
CoNS and Gram-negative bacilli accounted for 42 and 9% of
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TABLE 6 | Comparison of clinical manifestations, treatment, and outcomes between Gram-positive and Gram-negative pathogens.
Gram-positive cocci (N = 112) (%) Gram-negative bacilli (N = 20) (%) P
Clinical symptoms
Purulent exudate, n (%) 57 (50.9) 8 (40.0) 0.369
Device exposure, n (%) 26 (23.2) 10 (50.0) 0.013∗
Fever or chills, n (%) 5 (4.5) 5 (25.0) 0.001∗
Vegetation, n (%) 6 (5.4) 4 (20.0) 0.023∗
Antimicrobial therapy
Median duration (max, min), days 13 (9–16) 15.5 (10.5–18.75) 0.174
Adjustment based on culture results, n (%) 19 (17.0) 9 (45.0) 0.005∗
Inappropriate empirical therapy, n (%) 52 (47.7) 10 (50.0) 0.850
Outcomes
Poor wound healing, n (%) 5 (4.5) 2 (10.0) 0.309
Fever or chills, n (%) 16 (14.3) 4 (20.0) 0.511
Median length of stay (max, min), days 15 (13–19) 16.5 (14–22.5) 0.199
In-hospital death, n (%) 0 0 –
∗p < 0.05.
all infections, respectively, which were similar to our findings
(Sohail et al., 2007). However, in the United States study, S. aureus
was responsible for another 29% of infections, which was much
higher than that in our study (29% vs. 4.1%) (Sohail et al., 2007).
Of note, another study from Italy reported that CoNS, S. aureus,
and Gram-negative bacilli were detected in 69.0, 13.8, and 6.2%
of all culture-positive cases, respectively (Bongiorni et al., 2012).
In addition, a higher percentage of S. aureus was noted compared
to our study (13.8% vs. 6.1%). The high percentage of CoNS and
low percentage of S. aureus observed in our study may indicate
the involvement of host- or device-specific factors that favor
infection by CoNS over S. aureus. It has been demonstrated that
CoNS, compared with S. aureus, are likely to be introduced onto
device surfaces during insertion (Otto, 2009). In addition, CoNS
have been shown to be more adept at evading the host innate
immune system than S. aureus by being resistant to phagocytosis
by neutrophils (Guenther et al., 2009).
A number of associations between clinical characteristics
and different types of CIED infections were identified in our
study. Interestingly, previous studies have suggested that renal
insufficiency and diabetes mellitus are important risk factors for
CIED infections (Bloom et al., 2006). In our study, we observed
that 12.3 and 24.2% of patients with CIED infections had renal
diseases and diabetes mellitus, respectively. In addition, patients
with lung diseases were more likely to have early CIED infections.
These data indicate that patients with these underlying conditions
should be closely monitored after they receive a CIED. Moreover,
we found that patients with liver diseases had a higher chance of
systemic infections, suggesting that measures should be taken to
avoid systemic infections in these patients.
As our study suggests that most CIED infections were
introduced at the time of implantation, we recommend the use
of antimicrobial prophylaxis which covers Staphylococcus species
immediately before device insertion, as suggested by other studies
(De Oliveira et al., 2009; Sandoe et al., 2015b). It is noteworthy
that the majority of S. epidermidis isolates were resistant to
methicillin. As S. epidermidis was the predominant pathogen
causing CIED infections in our study, the clinical relevance of
our findings indicate that vancomycin should be used as first-
line empirical therapy, as suggested by other studies (Emilie
et al., 2012). In addition, based on our in vitro susceptibility test
results, other antimicrobials, including rifampicin, gentamicin
and linezolid, may be considered as alternatives for empirical
therapy, particularly when vancomycin cannot be tolerated.
However, it should be noted that when culture and in vitro
susceptibility results become available, antimicrobial therapy
should be adjusted accordingly.
In summary, our data describe the microbiological
characteristics and clinical features of CIED infections, and
provide evidence for advisory guidelines on the management of
CIED infections in China.
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